rss
J Clin Pathol 2006;59:580-584 doi:10.1136/jcp.2005.027292
  • Original article

Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40

  1. F Bergmann1,
  2. S Aulmann1,
  3. M N Wente2,
  4. R Penzel1,
  5. I Esposito1,
  6. J Kleeff2,
  7. H Friess2,
  8. P Schirmacher1
  1. 1Institute of Pathology and Department of Surgery, University of Heidelberg, Heidelberg, Germany
  2. 2Department of Surgery, University of Heidelberg
  1. Correspondence to:
    Dr F Bergmann
    Institute of Pathology, University of Heidelberg, Heidelberg, Im Neuenheimer Feld 220/221, 69120 Heidelberg, Germany; frank.bergmann{at}med.uni-heidelberg.de
  • Accepted 12 October 2005
  • Published Online First 23 February 2006

Abstract

Background: Pancreatic ductal adenocarcinoma (PDAC) rarely affects people under 40.

Objectives: To determine whether the clinical, pathomorphological and genetic features of PDAC occurring in young patients (≤40 years) differ from those in elderly patients.

Methods: Clinical and pathomorphological data were obtained from seven patients presenting with PDAC, with age ranging from 35 to 40 years of age (mean 38 years). All tumours were characterised by using immunohistochemistry and molecular genetics.

Results: All seven patients were women and lacked an association to cancer-predisposing genetic syndromes. Four patients were smokers and one had non-hereditary chronic pancreatitis. Pathomorphologically, tumours in three patients displayed moderate differentiation and four showed poor differentiation including one adenosquamous carcinoma. All tumours showed overexpression of transforming growth factor β1 and loss or significant reduction of Smad4. Accumulation of p53 and overexpression of epidermal growth factor receptor (EGFR) were seen in five and four patients, respectively. No expression of p16, oestrogen hormone receptor or progesterone receptor was found. Mismatch repair gene products (MutL homologue 1 (MLH1), MSH2 and MSH6) were expressed in all tumours. Mutational analyses showed K-ras mutations in only three of the seven tumours.

Conclusion: A large clinical, pathomorphological and genetic overlap of PDAC in young patients aged under 40 is seen with that in elderly patients. The existence of yet undefined initiating events of pancreatic carcinogenesis is suggested by the low rate of K-ras mutations, in at least a subgroup of young patients.

Footnotes

  • Published Online First 23 February 2006

  • Competing interests: None declared.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jcp.2005.027292v1
    2. 59/6/580 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.